Animal Therapeutics and Diagnostics

Summary

Study Goals And Objectives

This Bcc Research Report, Animal Therapeutics And Diagnostics, Provides An Overview Of Products Included In This Market, And Detailed Market Analyses And Competitive Environments. The Study Includes Information About Significant Products, Players, Issues And Trends, And Other Information Affecting The Animal Therapeutic And Diagnostic Market.

Reasons For Doing The Study

The Animal Health Industry Is Responsible For Maintaining The Health And Productivity Of The Over 3.3 Billion Livestock And 16 Billion Poultry Worldwide, And Ensuring The Wholesomeness And Abundance Of The Food They Produce. In Addition, The Industry Must Also Cater To The Health And Well Being Of Companion Animals. Despite This, The Human Healthcare Market Is 35 Times Larger Than The Combined Market For All Nonhuman Species. The Reality Is That The Global Animal Health Market Is Very Complex, Operating Under Stringent And Increasingly Strict Regulations Similar To Those For Human Health, Yet The Market Opportunities Are Considerably Smaller. In An Increasingly Risky Environment For New Product Development, The Difference Between Success And Failure In The Future Usually Lies In Successfully Identifying The Next Growth Segment, Developing The Right Product Candidates, And Being The First To Market. Despite All These Risks, The Industry Continues To Grow.

In Contrast To Human Blockbuster-Oriented Pharmaceuticals, Animal Health Is Dominated By Large Numbers Of Products With Small Revenues. Although There Are Hundreds Of Products Involved In This Market, Only About 2 Products Have Sales Exceeding $1 Million Per Year. However, The Industry Continues To Forge On. The Fastest Growing Therapeutic Categories Are In The Area Of Companion Animals, Specifically In The Arthritis And Pain Segments Of The Market.

A Challenging Aspect Of The Market Is Within The Animal Food Industry As Consumers Continue To Express Concern About The Conditions Under Which Their Daily Food Is Produced. Consumers Are Becoming More Health Conscious And Demanding Healthy And Balanced Diets. By Implementing A Feeding Plan That Provides Vitamins And Supplements, Consumers Enjoy Additional Nutritional Benefits. Additionally, Healthy Feeding Results In Minimized Impact On The Environment As Animals Produce Minimal Amounts Of Manure.

Intended Audience

The Information Within This Report Is Directed At The Business And Industry Professional And Is Specifically Designed To Aid In The Explanation, Direction, And Future Of Animal Health Markets. The Report Focuses On Providing The Reader With An Understanding Of Trends In The Industry, Market Segments, Market Forecasts, Leading Players, Market Drivers And Inhibitors.

Scope Of Report

This Bcc Research Report Is Designed To Be A Helpful Business Tool That Will Provide A Thorough Evaluation Of The Animal Therapeutic And Diagnostic Market. The Geographical Scope Of This Study Is Worldwide, With Special Interest In U.S. Trends And Statistics. The Report Identifies Markets In Four Segments: Vaccines, Pharmaceuticals, Feed Additives, And Diagnostics. For The Purpose Of This Study, Diagnostics Includes Products That Are Used At The Point Of Care And Are Considered Rapid Tests Or Kits. Each Market Segment Provides Detailed Information Based On Product Categories, Use Of Products, Forecasts, And Competitive Analyses.

Information Sources

The Information For This Bcc Report Was Obtained Through Primary And Secondary Data-Collection Methods. Primary Methods Included Interviews With Approximately 5 Key Executives, Product Managers, And Clinical Specialists Involved In The Animal Health Industry. Secondary Methods Included Published Literature In The Area Of Animal Science And Veterinary Services, Investment Reports, Company Literature, And Various Animal Health Journals.

All Market Data Pertains To The Global Market At The Manufacturers' Level. Data Is Expressed In Current U.S. Dollars. The Base Year Of The Report Is 27, With Historical Data Provided For 26, And Forecast Data Provided For 28 And 213. Historical, Base Year And Forecast Data Is Provided For Each Market Segment Of The Report. Competitor Market Share Estimates Are Provided For Each Market Segment For The 27 Base Year.

Although This Study Provides Information On A Variety Of Products Used To Treat Animals, It Does Not Include A Comprehensive List Of All Products Available.

Contents

• Introduction
• Study Goals And Objectives.
• Reasons For Doing The Study
• Intended Audience.
• Scope Of Report .
• Information Sourcesii
• Related Bcc Research Reportii
• Analyst Credentials.
• Bcc Research Online Services.
• Disclaimer
• Summary
• Summary Table Total Animal Therapeutic And
• Diagnostic Market By Major Segment, Through 213
• ($ Millions).
• Summary Figure Total Animal Therapeutic And
• Diagnostic Market By Major Segment, 26-213
• ($ Millions).
• Leading Products And Manufacturers
• Industry Overview
• Animal Anatomy And Physiology
• Animal Anatomy And Physiology
• Reproductive System
• Table Gestation Periods Of Select Common Species
• Avian Anatomy
• Avian Anatomy (Continued)
• Avian Anatomy (Continued)
• Animal Populations
• Companion Animals
• Table Estimated Populations Of Companion Animals
• For 27, United States (Thousands)
• Farm Animals
• Table Reported 25 And Estimated 26* Population Of
• Farm Animals, United States (Millions)
• Table Lifespan Of Common Pet Avian Species
• Companion Animal Diseases
• Infectious Diseases
• Viruses
• Adenovirus
• Avian Influenza
• Coronavirus
• Distemper
• Eastern Equine Encephalitis
• Equine Viral Arteritis
• Feline Calicivirus And Feline Herpes Virus
• Feline Immunosuppressive Virus
• Feline Infectious Peritonitis Virus
• Feline Leukemia Virus
• Infectious Hepatitis
• Internal Papillomatosis Of Parrots
• Newcastle Disease
• Pachecos Disease
• Parainfluenza Virus
• Paramyxoviruses
• Parvovirus
• Polyomavirus
• Poxviruses
• Psittacine Beak And Feather Disease
• Rabies
• Reovirus
• West Nile Virus
• Bacteria
• Black Tongue
• Bordetella
• Brucellosis
• Campylobacteriosis
• Chlamydia
• Leptospirosis
• Lyme Disease
• Q-Fever
• Respiratory Mycoplasmosis
• Spirochaetaceae
• Tetanus
• Allergy And Inflammatory Diseases
• Allergies
• Arthritis
• Asthma
• Dermatitis
• Eosinophilic Granuloma Complex
• Gout
• Inflammatory Bowel Disease
• Metabolic Diseases
• Cushings Syndrome
• Diabetes Mellitus
• Thyroid Disease
• Pancreatitis
• Metabolic Bone Disease In Birds
• Parasitic Diseases
• Ear Mites
• Fleas
• Heartworm
• Hemobartonellosis
• Feline Scabies
• Lice
• Sarcoptic Mange
• Worms
• Urinary Diseases
• Glomerulonephritis
• Feline Lower Urinary Tract Disease
• Other Diseases
• Equine Protozoal Myelitis
• Leptospirosis And Equine Recurrent Uveitis
• Neoplastic Disease
• Neoplastic Disease (Continued)
• Heart Disease
• Food Animal Diseases
• Infectious Diseases
• Viruses And Prions
• Avian Pneumovirus
• Bovine Spongiform Encephalopathy
• Bovine Viral Diarrhea
• Bovine Viral Diarrhea (Continued)
• Classical Swine Fever
• Foot And Mouth Disease
• Furunculosis
• Infectious Pancreatic Necrosis
• Mareks Disease
• Pathogenic Avian Influenza
• Q-Fever
• Vesicular Stomatitis
• Bacteria
• Anthrax
• Blackleg
• Conjunctivitis
• Tetanus
• Other Diseases Of Food Animals
• Heartwater
• Pneumonia
• Texas Cattle Fever
• Zoonotic Diseases
• Zoonotic Diseases
• Table Common Examples Of Zoonotic Diseases
• Issues Affecting The Market
• Antibiotic Use And Resistance In Food Animals
• Therapeutic Use
• Table Approved Antibiotics And Sulfonamides Used In
• Diary And Beef Cattle Production In U.S
• Table Approved Antibiotics Used In Hog Production In
• U.S
• Table Approved Antibiotics Used In Sheep Production
• In U.S
• Table Approved Antibiotics Used In Chicken And
• Turkey Production In U.S
• Resistance
• Human Side-Effects
• Microbial Ecology
• Probiotics
• Legal And Regulatory Issues
• Minimally And Highly Regulated Products
• Animal Drug User Fee Act Of 23
• Animal Health Insurance
• Animal Health Insurance (Continued)
• Spray-On Drugs
• Biotechnology
• Animal Obesity
• Causes
• Weight Reduction
• New Trends In Aging Diseases
• Companion Pet Ownership
• Demand In The Veterinary Service Industry
• Table Estimated Number Of Veterinarian Practices In
• The United States By Type Of Practice, 27
• Life Cycle Approach
• International Issues And Trends
• Table Estimated Populations Of Companion Animals
• For 25, Japan And Australia (Millions)
• Table Estimated Populations Of Farm Animals For
• 24, Brazil (Millions)
• Animal Vaccines
• Overview
• Product Description
• Active Immunity
• Passive Immunity
• Other Types
• Target Species And Providers
• Table Vaccines By Target Species And Providers
• Companion Animal Vaccines
• Boehringer Ingelheim
• Fort Dodge
• Heska
• Merial
• Novartis
• Schering-Plough
• Food Animal Vaccines
• Alpharma
• Bayer
• Boehringer Ingelheim
• Fort Dodge
• Intervet
• Merial
• Novartis
• Pfizer
• Schering-Plough
• Poultry
• Poultry (Continued)
• Poultry (Continued)
• Poultry (Continued)
• Cattle And Sheep
• Swine
• Rabies
• Fish
• Market Analysis And Conclusions
• Markets By Use Or Application
• Table Global Market Analysis For Animal Vaccines
• By Use, Through 213 ($ Millions)
• Figure Gobal Market Analysis For Animal Vaccines By
• Use, 26-213 ($ Millions)
• Vaccine Market By Type
• Table Estimated Global Revenues For Animal
• Vaccines By Type, Through 213 ($ Millions)
• Figure Estimated Global Revenues For Animal
• Vaccines By Type, 26-213 ($ Millions)
• Markets By Geographical Region
• Table Distribution Of Revenues For Animal Vaccines
• By World Region, 27 (%/$ Millions)
• Figure Distribution Of Revenues For Animal Vaccines
• By World Region, 27 (%)
• Competitive Summary
• Intervet
• Schering-Plough
• Fort Dodge
• Other Companies
• Table Competitive Summary For Animal Vaccines By
• Competitor Revenue, 27 (%/$ Millions)
• Figure Competitive Summary For Animal Vaccines By
• Competitor Revenue, 27 (%)
• Animal Pharmaceutical Products
• Overview
• Product Description
• Allergy And Respiratory Drugs
• Target Species And Providers
• Table Allergy And Respiratory Drugs By Target
• Species And Providers
• Anti-Infectives And Antifungals
• Bayer
• Boehringer Ingelheim
• Elanco
• Esteve
• Fort Dodge
• Eco
• Novartis
• Pfizer
• Schering-Plough
• Target Species And Providers
• Table Anti-Infectives By Target Species And
• Providers
• Anti-Inflammatories And Analgesics
• Bayer
• Boehringer Ingelheim
• Elanco
• Esteve
• Fort Dodge
• Bioniche
• Novartis
• Pfizer
• Schering-Plough
• Luitpold Animal Health
• Target Species And Providers
• Table Anti-Inflammatories And Analgesics By Target
• Species And Providers
• Metabolic Drugs
• Target Species And Providers
• Table Metabolic Drugs By Target Species And
• Providers
• Parasiticides
• Bayer
• Boehringer-Ingelheim
• Esteve
• Fort Dodge
• Ide
• Eco
• Merial
• Novartis
• Pfizer
• Schering-Plough
• Virbac
• Target Species And Providers
• Table Parasiticides By Target Species And Providers
• Other Pharmaceuticals
• Esteve
• Merial
• Schering-Plough
• Dental
• Virbac
• Biopure
• Novartis
• Target Species And Providers
• Table Other Pharmaceuticals By Target Species And
• Providers
• Market Analysis And Conclusions
• Markets By Use Or Application
• Allergy And Respiratory Market
• Table Global Market Analysis For Allergy And
• Respiratory Products By Use, Through 213
• ($ Millions)
• Figure Global Market Analysis For Allergy And
• Respiratory Products By Use, 26-213 ($ Millions)
• Anti-Infective Market
• Table Global Market Analysis For Anti-Infectives By
• Use, Through 213 ($ Millions)
• Figure Global Market Analysis For Anti-Infectives By
• Use, 26-213 ($ Millions)
• Anti-Inflammatory Market
• Table Global Market Analysis For Antiinflammatories
• And Analgesics By Use, Through 213
• ($ Millions)
• Figure Global Market Analysis For Antiinflammatories
• And Analgesics By Use, 26-213
• ($ Millions)
• Metabolic Drug Market
• Table Global Market Analysis For Metabolic Drugs
• By Use, Through 213 ($ Millions)
• Figure Global Market Analysis For Metabolic Drugs
• By Use, 26-213 ($ Millions)
• Parasiticide Market
• Table Global Market Analysis For Parasiticides By
• Use, Through 213 ($ Millions)
• Figure Global Market Analysis For Parasiticides By
• Use, 26-213 ($ Millions)
• Other Pharmaceuticals
• Table Global Market Analysis For Other
• Pharmaceuticals By Use, Through 213 ($ Millions)
• Figure Global Market Analysis For Other
• Pharmaceuticals By Use, 26-213 ($ Millions)
• Total Pharmaceuticals
• Table Global Market Analysis For Animal
• Pharmaceutical Products By Use, Through 213
• ($ Millions)
• Figure Global Market Analysis For Animal
• Pharmaceutical Products By Use, 26-213 ($ Millions)
• Summarypharmaceutical Markets
• Table Global Market Analysis For Animal
• Pharmaceutical Products By Type, Through 213
• ($ Millions)
• Figure Global Market Analysis For Animal
• Pharmaceutical Products By Type, 26-213
• ($ Millions)
• Markets By Geographical Region
• Table Distribution Of Revenues For Animal
• Pharmaceuticals By World Region, 27 (%)
• Figure Distribution Of Revenues For Animal
• Pharmaceuticals By World Region, 27 (%)
• Competitive Summary
• Table Competitive Summary For Animal
• Pharmaceutical Products By Competitor Revenues,
• 27 (%/$ Millions)
• Figure Competitive Summary For Animal
• Pharmaceutical Products By Competitor Revenues,
• 27 (%)
• Animal Feed Additives
• Overview
• Product Description
• Amino Acids
• Target Species And Providers
• Table Amino Acids By Target Species And Providers
• Medicinal Additives
• Alpharma
• Elanco
• Eco
• Novartis
• Merial
• Pfizer
• Schering-Plough
• Boehringer Ingelheim
• Target Species And Providers
• Table Medicinal Additives By Target Species And
• Providers
• Nutritional Supplements
• Nutritional Supplements
• Target Species And Providers
• Table Nutritional Supplements By Target Species
• And Providers
• Vitamins And Minerals
• Beaphar
• Esteve
• Adisseo
• Mosaic (Formerly Imc Global)
• Dsm Nutritional
• Schering-Plough
• Church & Dwight Co
• Virbac
• Target Species And Providers
• Table Vitamins And Minerals By Target Species And
• Providers
• Market Analysis And Conclusion
• Markets By Use Or Application
• Amino Acid Market
• Table Global Market Analysis For Amino Acids By Use,
• Through 213 ($ Millions)
• Figure Market Analysis For Amino Acids By Use, 26-
• 213 ($ Millions)
• Medicinal Feed Additive Market
• Table Global Market Analysis For Medicinal Feed
• Additives By Use, Through 213 ($ Millions)
• Figure Global Market Analysis For Medicinal Feed
• Additives By Use, 26-213 ($ Millions)
• Nutritional Supplement Market
• Table Global Market Analysis For Nutritional
• Supplements By Use, Through 213 ($ Millions)
• Figure Global Market Analysis For Nutritional
• Supplements By Use, 26-213 ($ Millions)
• Vitamin And Mineral Market
• Table Global Market Analysis For Vitamins And
• Minerals By Use, Through 213 ($ Millions)
• Figure Global Market Analysis For Vitamins And
• Minerals By Use, 26-213 ($ Millions)
• Total Feed Additive Market
• Table Global Market Analysis For Animal Feed
• Additives By Use, Through 213 ($ Millions)
• Figure Global Market Analysis For Animal Feed
• Additives By Use, 26-213 ($ Millions)
• Feed Additive Market By Type
• Table Global Market Analysis For Animal Feed
• Additive Products By Type, Through 213 ($ Millions)
• Figure Global Market Analysis For Animal Feed
• Additive Products By Type, 26-213 ($ Millions)
• Markets By Geographical Region
• Table Distribution Of Revenues For Animal Feed
• Additives By World Region, 27 (%/$ Millions)
• Figure Distribution Of Revenues For Animal Feed
• Additives By World Region, 27 (%)
• Competitive Summary
• Table Competitive Summary For Animal Feed
• Additives By Competitor Revenues, 27 (%/$ Millions)
• Figure Competitive Summary For Animal Feed
• Additives By Competitor Revenues, 27 (%)
• Animal Diagnostics
• Overview
• Product Description
• Heska
• Ide
• Snap
• Petchek
• Diasystems
• Herdchek
• Flockchek
• Guildhay And Svanovir
• Schering-Plough
• Synbiotics
• Target Species And Providers
• Table Diagnostics By Target Species And Providers
• Market Analysis And Conclusion
• Markets By Use Or Application
• Table Global Market Analysis For Animal
• Diagnostics Products By Use, Through 213
• ($ Millions)
• Figure Global Market Analysis For Animal
• Diagnostics By Use, 26-213 ($ Millions)
• Diagnostic Market By Type
• Table Estimated Revenues For Animal Diagnostics By
• Type, Through 213 ($ Millions)
• Figure Estimated Revenues For Animal Diagnostics
• By Type, 26-213 ($ Millions)
• Markets By Geographical Region
• Table Distribution Of Revenues For Animal
• Diagnostics By World Region, 27 (%/$ Millions)
• Figure Distribution Of Revenues For Animal
• Diagnostics By World Region, 27 (%)
• Competitive Summary
• Table Competitive Summary For Animal Diagnostics
• By Competitor Revenues, 27 (%/$ Millions)
• Figure Competitive Summary For Animal Diagnostics
• By Competitor Revenues, 27 (%)
• Market Summary
• Total Animal Therapeutics And Diagnostic Market
• Analysis
• Table Global Market Analysis For Animal
• Therapeutics And Diagnostics By Product Segment,
• Through 213 ($ Millions)
• Figure Global Market Analysis For Animal
• Therapeutics And Diagnostics By Type, Through 213
• ($ Millions)
• Table Global Market Analysis For Animal
• Therapeutics And Diagnostics By Animal Type,
• Through 213 ($ Millions)
• Figure Global Market Analysis For Animal
• Therapeutics And Diagnostics By Animal Type, 26-213
• ($ Millions)
• Industry Participants By Type
• Table Major Industry Participants By Animal
• Product Type
• Total Competitive Analysis
• Table Total Competitive Market Share For Animal
• Therapeutics And Diagnostics By Manufacturer
• Revenues, 27 (%/$ Millions)
• Figure Total Competitive Summary For Animal
• Therapeutics And Diagnostics By Competitor
• Revenues, 27 (%)
• Company Profiles
• Adisseo France S.A.S
• Alpharma, Inc
• Basf Animal Nutrition (Basf Ag)
• Bayer Animal Health
• Boehringer Ingelheim Corp
• Dsm Nutritional Products
• Elanco Animal Health
• Evonik Industries
• Fort Dodge Animal Health
• Heska Corp
• Ide Laboratories, Inc
• Intervet International Bv
• Ivx Animal Health, Inc
• Merial Animal Health, Ltd
• Mosaic
• Novartis Animal Health, Inc
• Novartis Ag
• Novus International, Inc
• Pfizer Animal Health
• Schering-Plough Animal Health
• Schering-Plough Corp
• Virbac Sa
• Virbac Sa
• Appendix : Leading Manufactures And Affiliated
• Companies
• Acrux, Ltd
• Adisseo France S.A.S
• Ajinomoto Co., Ltd
• Akzo Nobel N.
• Alpharma, Inc
• Basf Ag
• Basf Animal Nutrition
• Bayer Ag
• Bayer Healthcare, Llc
• Beaphar B.
• Ben Venue Laboratories, Inc
• Boehringer Ingelheim Chemicals, Inc
• Boehringer Ingelheim Corp
• Boehringer Ingelheim Gmbh
• Boehringer Ingelheim Vetmedica, Inc
• Dsm
• Dsm Nutritional Products
• Eco Animal Health
• Elanco Animal Health
• Eli Lilly & Co
• Esteve
• Evonik Degussa Gmbh
• Fort Dodge Animal Health
• Heska Corp
• Ide Laboratories, Inc
• Intervet International Bv
• Luitpold Animal Health
• Mosaic
• Merial Animal Health, Ltd
• Novartis Ag
• Novartis Animal Health, Inc
• Novartis Animal Vaccines, Inc
• Novus International, Inc
• Pfizer Animal Health
• Pfizer, Inc
• Roxane Laboratories, Inc
• Schering-Plough Animal Health
• Schering-Plough Corp
• Synbiotics Corp
• Virbac S.A
• Wyeth
• Appendix : Relevant Associations And Organizations
• American Association Of Feline Practitioners
• American Veterinary Medical Association
• Canadian Veterinary Medical Association
• United States Department Of Agriculture
• United States Food And Drug Administration
• List Of Tables
• Summary Table Total Animal Therapeutic And Diagnostic
• Market By Major Segment, Through 213 ($ Millions)
• Table Gestation Periods Of Select Common Species
• Table Estimated Populations Of Companion Animals For
• 27, United States (Thousands)
• Table Reported 25 And Estimated 26* Population Of
• Farm Animals, United States (Millions)
• Table Lifespan Of Common Pet Avian Species
• Table Common Examples Of Zoonotic Diseases
• Table Approved Antibiotics And Sulfonamides Used In
• Diary And Beef Cattle Production In U.S
• Table Approved Antibiotics Used In Hog Production In
• U.S
• Table Approved Antibiotics Used In Sheep Production In
• U.S
• Table Approved Antibiotics Used In Chicken And Turkey
• Production In U.S
• Table Estimated Number Of Veterinarian Practices In
• The United States By Type Of Practice, 27
• Table Estimated Populations Of Companion Animals For
• 25, Japan And Australia (Millions)
• Table Estimated Populations Of Farm Animals For 24,
• Brazil (Millions)
• Table Vaccines By Target Species And Providers
• Table Global Market Analysis For Animal Vaccines By
• Use, Through 213 ($ Millions)
• Table Estimated Global Revenues For Animal Vaccines
• By Type, Through 213 ($ Millions)
• Table Distribution Of Revenues For Animal Vaccines By
• World Region, 27 (%/$ Millions)
• Table Competitive Summary For Animal Vaccines By
• Competitor Revenue, 27 (%/$ Millions)
• Table Allergy And Respiratory Drugs By Target
• Species And Providers
• Table Anti-Infectives By Target Species And Providers
• Table Anti-Inflammatories And Analgesics By Target
• Species And Providers
• Table Metabolic Drugs By Target Species And Providers
• Table Parasiticides By Target Species And
• Providers
• List Of Tables
• Table Other Pharmaceuticals By Target Species And
• Providers
• Table Global Market Analysis For Allergy And
• Respiratory Products By Use, Through 213 ($ Millions)
• Table Global Market Analysis For Anti-Infectives By
• Use, Through 213 ($ Millions)
• Table Global Market Analysis For Anti-Inflammatories
• And Analgesics By Use, Through 213 ($ Millions)
• Table Global Market Analysis For Metabolic Drugs By
• Use, Through 213 ($ Millions)
• Table Global Market Analysis For Parasiticides By Use,
• Through 213 ($ Millions)
• Table Global Market Analysis For Other
• Pharmaceuticals By Use, Through 213 ($ Millions)
• Table Global Market Analysis For Animal
• Pharmaceutical Products By Use, Through 213
• ($ Millions)
• Table Global Market Analysis For Animal
• Pharmaceutical Products By Type, Through 213
• ($ Millions)
• Table Distribution Of Revenues For Animal
• Pharmaceuticals By World Region, 27 (%)
• Table Competitive Summary For Animal Pharmaceutical
• Products By Competitor Revenues, 27 (%/$ Millions)
• Table Amino Acids By Target Species And Providers
• Table Medicinal Additives By Target Species And
• Providers
• Table Nutritional Supplements By Target Species And
• Providers
• Table Vitamins And Minerals By Target Species And
• Providers
• Table Global Market Analysis For Amino Acids By Use,
• Through 213 ($ Millions)
• Table Global Market Analysis For Medicinal Feed
• Additives By Use, Through 213 ($ Millions)
• Table Global Market Analysis For Nutritional
• Supplements By Use, Through 213 ($ Millions)
• Table Global Market Analysis For Vitamins And
• Minerals By Use, Through 213 ($ Millions)
• Table Global Market Analysis For Animal Feed
• Additives By Use, Through 213 ($ Millions)
• List Of Tables
• Table Global Market Analysis For Animal Feed Additive
• Products By Type, Through 213 ($ Millions)
• Table Distribution Of Revenues For Animal Feed
• Additives By World Region, 27 (%/$ Millions)
• Table Competitive Summary For Animal Feed Additives
• By Competitor Revenues, 27 (%/$ Millions)
• Table Diagnostics By Target Species And Providers
• Table Global Market Analysis For Animal Diagnostics
• Products By Use, Through 213 ($ Millions)
• Table Estimated Revenues For Animal Diagnostics By
• Type, Through 213 ($ Millions)
• Table Distribution Of Revenues For Animal Diagnostics
• By World Region, 27 (%/$ Millions)
• Table Competitive Summary For Animal Diagnostics By
• Competitor Revenues, 27 (%/$ Millions)
• Table Global Market Analysis For Animal Therapeutics
• And Diagnostics By Product Segment, Through 213
• ($ Millions)
• Table Global Market Analysis For Animal Therapeutics
• And Diagnostics By Animal Type, Through 213
• ($ Millions)
• Table Major Industry Participants By Animal Product
• Type
• Table Total Competitive Market Share For Animal
• Therapeutics And Diagnostics By Manufacturer
• Revenues, 27 (%/$ Millions)
• List Of Figures
• Summary Figure Total Animal Therapeutic And
• Diagnostic Market By Major Segment, 26-213
• ($ Millions)
• Figure Gobal Market Analysis For Animal Vaccines By
• Use, 26-213 ($ Millions)
• Figure Estimated Global Revenues For Animal Vaccines
• By Type, 26-213 ($ Millions)
• Figure Distribution Of Revenues For Animal Vaccines By
• World Region, 27 (%)
• Figure Competitive Summary For Animal Vaccines By
• Competitor Revenue, 27 (%)
• Figure Global Market Analysis For Allergy And
• Respiratory Products By Use, 26-213 ($ Millions)
• Figure Global Market Analysis For Anti-Infectives By
• Use, 26-213 ($ Millions)
• Figure Global Market Analysis For Anti-Inflammatories
• And Analgesics By Use, 26-213 ($ Millions)
• Figure Global Market Analysis For Metabolic Drugs By
• Use, 26-213 ($ Millions)
• Figure Global Market Analysis For Parasiticides By Use,
• 26-213 ($ Millions)
• Figure Global Market Analysis For Other
• Pharmaceuticals By Use, 26-213 ($ Millions)
• Figure Global Market Analysis For Animal
• Pharmaceutical Products By Use, 26-213 ($ Millions)
• Figure Global Market Analysis For Animal
• Pharmaceutical Products By Type, 26-213 ($ Millions)
• Figure Distribution Of Revenues For Animal
• Pharmaceuticals By World Region, 27 (%)
• Figure Competitive Summary For Animal
• Pharmaceutical Products By Competitor Revenues, 27
• (%)
• Figure Market Analysis For Amino Acids By Use, 26-213
• ($ Millions)
• Figure Global Market Analysis For Medicinal Feed
• Additives By Use, 26-213 ($ Millions)
• Figure Global Market Analysis For Nutritional
• Supplements By Use, 26-213 ($ Millions)
• Figure Global Market Analysis For Vitamins And
• Minerals By Use, 26-213 ($ Millions)
• List Of Figures
• Xi
• Figure Global Market Analysis For Animal Feed
• Additives By Use, 26-213 ($ Millions)
• Figure Global Market Analysis For Animal Feed
• Additive Products By Type, 26-213 ($ Millions)
• Figure Distribution Of Revenues For Animal Feed
• Additives By World Region, 27 (%)
• Figure Competitive Summary For Animal Feed Additives
• By Competitor Revenues, 27 (%)
• Figure Global Market Analysis For Animal Diagnostics
• By Use, 26-213 ($ Millions)
• Figure Estimated Revenues For Animal Diagnostics By
• Type, 26-213 ($ Millions)
• Figure Distribution Of Revenues For Animal
• Diagnostics By World Region, 27 (%)
• Figure Competitive Summary For Animal Diagnostics By
• Competitor Revenues, 27 (%)
• Figure Global Market Analysis For Animal
• Therapeutics And Diagnostics By Type, Through 213
• ($ Millions)
• Figure Global Market Analysis For Animal
• Therapeutics And Diagnostics By Animal Type, 26-213
• ($ Millions)
• Figure Total Competitive Summary For Animal
• Therapeutics And Diagnostics By Competitor Revenues,
• 27 (%)